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Abstract
Loss of integrity of the epithelial/mucosal barrier in the small intestine has been associated with different pathologies that
originate and/or develop in the gastrointestinal tract. We showed recently that mucin, the main protein in the mucus layer,
is disrupted during early periods of intestinal ischemia. This event is accompanied by entry of pancreatic digestive enzymes
into the intestinal wall. We hypothesize that the mucin-containing mucus layer is the main barrier preventing digestive
enzymes from contacting the epithelium. Mucin breakdown may render the epithelium accessible to pancreatic enzymes,
causing its disruption and increased permeability. The objective of this study was to investigate the role of mucin as a
protection for epithelial integrity and function. A rat model of 30 min splanchnic arterial occlusion (SAO) was used to study
the degradation of two mucin isoforms (mucin 2 and 13) and two epithelial membrane proteins (E-cadherin and toll-like
receptor 4, TLR4). In addition, the role of digestive enzymes in mucin breakdown was assessed in this model by luminal
inhibition with acarbose, tranexamic acid, or nafamostat mesilate. Furthermore, the protective effect of the mucin layer
against trypsin-mediated disruption of the intestinal epithelium was studied in vitro. Rats after SAO showed degradation of
mucin 2 and fragmentation of mucin 13, which was not prevented by protease inhibition. Mucin breakdown was
accompanied by increased intestinal permeability to FITC-dextran as well as degradation of E-cadherin and TLR4. Addition
of mucin to intestinal epithelial cells in vitro protected against trypsin-mediated degradation of E-cadherin and TLR4 and
reduced permeability of FITC-dextran across the monolayer. These results indicate that mucin plays an important role in the
preservation of the mucosal barrier and that ischemia but not digestive enzymes disturbs mucin integrity, while digestive
enzymes actively mediate epithelial cell disruption.
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Introduction
The intestinal epithelium covering the gastrointestinal tract
consists of a monolayer of enterocytes covered by a mucus gel
layer. Together these two layers provide a dynamic and regulated
barrier allowing selective passage of luminal contents into the
intestinal wall. Loss of the epithelial/mucus layer integrity is a
common feature in gastrointestinal diseases [1,2] and intestinal
ischemia encountered in different forms of shock [3,4,5].
The mucus gel layer, which ranges in thickness from 50–
300 mm [6], is a hydrated polymeric gel composed of carbohy-
drates, lipids and protein [7]. The major protein component of the
mucus layer is mucin, which consists of several isoforms, both
secreted and membrane associated. Mucin is believed to protect
the epithelial surface of the small intestine from luminal digestive
enzymes, abrasion by food particles, and pathogens by forming a
barrier between the lumen and the intestinal epithelium
[8,9,10,11]. The epithelial cells also form a selective barrier to
molecules found in the lumen; this barrier depends on the integrity
of intercellular junctions and the extracellular plasma membrane
proteins. Changes in the environment of epithelial cells make these
molecules targets for proteolytic attack [12], cause disruption of
cell structure components influencing intracellular signaling
[13,14,15], and impair epithelial barrier function [16].
Intestinal epithelial cells express numerous membrane proteins
on the plasma membrane whose fate after disruption of the mucin
layer is uncertain. We have reported that E-cadherin, which plays
a major role in maintaining the intercellular junctions between
epithelial cells [17] is degraded during intestinal ischemia [3].
Conversely the fate of other membrane molecules, e.g. toll-like
receptor 4 (TLR4), which is usually associated with infection and
sepsis [18,19] and recently has been linked to hemorrhagic shock
and intestinal ischemia [20,21], remains unknown. Since during
ischemia disruption of mucin 2 (secreted) and mucin 13
(membrane bound) is accompanied by transport of digestive
enzymes into the intestinal wall, we hypothesized that mucin is a
barrier to luminal digestive enzymes under normal physiological
conditions, as contact by digestive enzymes with the epithelium
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e40087due to the absence or degradation of mucin results in receptor
destruction and loss of epithelial cell integrity and function.
In this study we studied whether mucin disruption observed
during intestinal ischemia is accompanied by impaired epithelial
cell integrity and function. Using a rat model of intestinal ischemia
by splanchnic arterial occlusion (SAO) we studied the fate of two
mucin isoforms (mucin 2 and mucin 13) and two selected
membrane proteins (E-cadherin and TLR4), as well as mucin 2
mRNA levels during and after the ischemic period. We also
examined the effect of digestive enzymes on mucin and epithelial
cell disruption by luminal amylase inhibition with acarbose and
serine protease inhibition with tranexamic acid and nafamostat
mesilate. Furthermore, we utilized rat intestinal epithelial cell
cultures to demonstrate that addition of a mucin layer on the
apical side protects epithelial cells against trypsin-mediated
disruption.
Materials and Methods
Animal Groups and SAO Model
All animal protocols were reviewed and approved by the
University of California San Diego Animal Subjects Committee.
Male Wistar rats (300–350 g, Harlan Sprague Dawley Inc,
Indianapolis, IN) were randomly assigned to one of five groups
(n=4 per group): a sham group (SHAM), and four groups
subjected to 30 min splanchnic ischemia without enteral protease
inhibition (SAO30) and with enteral amylase inhibition by
acarbose (SAO30+ACA), protease inhibition by tranexamic acid
(SAO30+TA) and nafamostat mesilate (ANGD, [6-amidino-2-
naphthyl p-guanidinobenzoate dimethanesulfonate])
(SAO+ANGD). Rats were kept on solid food restriction for 12
hours prior to surgery with water ad libitum.
After general anesthesia (Ketamine/Xylazine, 75 mg/kg Body
Weight (BW)/20 mg/kg BW, intra-muscular) all groups were
injected 0.9% saline (3 ml/100 g BW) into the lumen of the
intestine either alone (SHAM or SAO30 groups) or mixed with
one of three enzyme inhibitors (SAO30+ACA, SAO30+TA, or
SAO30+ANGD groups). The concentration of the enzyme
inhibitors was as follows: acarbose (0.5 mg/100 g BW) and
tranexamic acid (0.1 g/100 g BW) (Sigma-Aldrich, St Louis,
MO) or nafamostat mesilate (5 mg/100 g BW, Torii Pharmaceu-
tical Co. Ltd., Tokyo, Japan). 30 min after saline or saline/
inhibitor injection, the superior mesenteric and celiac arteries were
isolated and occluded for 30 min for the ischemic groups or
isolated without occlusion in the sham group. After 30 min SAO
or sham surgery the animals were euthanized with BeuthanasiaH
0.22 ml/kg BW, intra-venous.
Assessment of Intestinal Permeability In-Vivo
In separate experiments, rat jejunal sections were assayed for in
vivo FITC-dextran transport (20 kDa, Sigma-Aldrich) from the
lumen of the intestine into the intestinal wall. Groups were the
same as described above with FITC-dextran (100 mg/ml) added
to saline or saline/inhibitor solution prior to injection in the lumen
of the intestine followed by 30 minutes ischemia or sham surgery
and euthanasia.
Tissue Cryosections
After euthanasia, jejunal sections (,1 cm in length) were
excised without removal of luminal contents and suspended in
Tissue-Tek O.C.T. Compound (Sakura Finetek, Torrance, CA),
snap frozen in isopentane/liquid nitrogen, and stored at 280uC
for analysis. Cryosections (5 mm thickness) along the longitudinal
axis of the villi were used throughout all experiments. Cryosections
Figure 1. Inhibitory profile of acarbose and nafamostat mesilate. Lineweaver-Burk Plot with inset Michaelis-Menten plot of amylase activity
with different concentrations of acarbose (A) and trypsin activity with different concentrations of nafamostat mesilate (B). Enzyme kinetic parameters,
maximum enzyme velocity (Vmax, RFU/min.mg), Michaelis-Menten constant (Km,m Mo rmM) for amylase or trypsin with different concentrations of
inhibitors calculated after non-linear regression (C).
doi:10.1371/journal.pone.0040087.g001
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in intestine homogenates of SHAM animals or animals subjected to SAO protocol with luminal inhibition using acarbose (ACA), tranexamic acid (TA)
or nafamostat mesilate or without (NI). Activity of luminal contents of SHAM intestines for each enzyme is shown at the end of the graphs. Western
blot for amylase, trypsin and b-actin in intestine homogenates of groups described above (C) with corresponding density levels measurements (D, E).
Values are mean6SEM (n=4)/group **P,0.001 compared to SHAM, {{{P,0.0001 compared to SAO30, {P,0.05 and {{P,0.001 compared to ACA,
111 P,0.0001 compared to all the other groups.
doi:10.1371/journal.pone.0040087.g002
Figure 3. In situ zymography for trypsin in jejunal sections. Representative micrographs of trypsin activity as observed by fluorescence of
specific substrate (blue), nuclei counterstaining with propidum iodine (red) in SHAM animals or animals subjected to SAO protocol with luminal
inhibition with acarbose (ACA), tranexamic acid (TA) or nafamostat mesilate or without inhibitors (SAO30).
doi:10.1371/journal.pone.0040087.g003
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blinded fashion.
In-situ Tissue Zymography and Immunohistochemistry
In-situ zymography for trypsin activity in cryosections was
assessed by measurement of fluorescence resulting from the
proteolytic cleavage of the substrate (1 mM, Na-benzoyl-L-
arginine-7-amido-methylcoumarin hydrochloride; Sigma-Aldrich)
as described elsewhere [22]. For immunohistochemical analysis,
primary antibodies were diluted as followed: Trypsin 1:300 and
mucin2 1:200 (Santa Cruz Biotechnology, Santa Cruz, CA); the
extracellular domain of TLR4 1:250 (Abcam, Cambridge, MA),
and the intracellular domain of TLR4 1:250 (Invitrogen,
Carlsbad, CA, USA). Secondary antibodies were as follows: FITC
(Santa Cruz Biotechnology) and HRP (ImmPRESS, Vector Lab;
Burlingame, CA). The slides were developed using 3, 39-
diaminodbenzidine substrate and counterstained with hematoxylin
or DAPI (Vector Lab) or propidium iodine (Sigma-Aldrich). Slides
were observed in a non-blinded fashion under an inverted
microscope (206and 606objectives).
Homogenates of Intestine and Luminal Contents
Jejunal segments were excised without removal of luminal
contents. For enzyme activity measurements, segments of intestine
were homogenized with CelLytic
TM (Sigma-Aldrich) without
addition of protease inhibitors. For Western blot assays the
intestine segments were homogenized as above in the presence of
protease inhibitors (5 mM EDTA, 5 mM N-Ethylmaleimide,
25 mM iodoacetamide, 5 mM benzamidine, 300 mM acarbose,
5 mM 6-aminocaproic acid, 1 mM protease inhibitor cocktail,
(Sigma-Aldrich). In separate experiments the small intestine of
sham animals was excised, and the luminal contents were flushed
with 20 ml saline. Homogenates or luminal contents were
centrifuged (16,000 g for 15 min at 4uC), the supernatant was
collected and protein concentration was assessed with the
bicinchoninic acid protein assay (Thermo Scientific).
Enzyme Activity
Activity of intestine homogenates (100 mg of protein), luminal
contents (50 mg of protein), or 50 mg/ml purified enzyme (porcine
trypsin and amylase) was measured with substrates specific for
trypsin and papain (50 mM, Na-benzoyl-L-arginine-7-amido-
methylcoumarin hydrochloride) [23], and amylase (4 mM, 2-
Chloro-4-nitrophenyl-a-D-maltotrioside, Sigma-Aldrich) [24].
The initial rates of hydrolysis were measured by the fluorescent
intensity of 7-amido-4-methylcoumarin, 380/460 nm (excitation/
emission) or the absorbance of 2-Chloro-4-nitrophenol at 405 nm
(SpectraMax Gemini XS, Molecular Devices, Sunnyvale, CA). The
enzymaticinhibitorypropertiesofacarboseandnafamostatmesilate
were confirmed by incubation of amylase or trypsin with different
concentrations of inhibitors for 30 minutes, followed by incubation
with the specific substrates. The initial velocity of the reaction was
expressed as the rate of change of Relative Units (RU) per mgo f
protein per minute. The data wasfitted witha non-linear regression
of the Michaelis-Menten or Lineweaver-Burk equations and kinetic
constants (maximum enzyme velocity, Vmax, Michaelis-Menten
constant, Km, and inhibitory constant, Ki) were computed
(GraphPad Prism, Graphpad Software, San Diego, CA).
Quantitative PCR (qPCR)
Total-RNA was isolated from jejunal segments (SHAM (n=6)
and SAO30; n=4 for SAO30+ACA, SAO30+TA and
SAO30+ANGD) using RNeasy kit (Qiagen, Valencia, CA), and
the total RNA was quantified by optical density. cDNA was
generated (iScript cDNA synthesis kit, BioRad Laboratories,
Richmond, CA) and qPCR reactions were performed (SYBR
Green,Biorad).Theprimersequencesusedforratmucin2(MUC2)
were designed from the fragment of Rattus norvegicus mucin mRNA
(GI 506641): 59-CAGAGTGCATCAGTGGCTGT-39 (forward)
and 59-CCCGTCGAAGGTGATGTAGT-39 (reverse). ß-actin
was used as a reference gene, chosen and designed from the ß-
actin mRNA (GI 42475962): 59-AACTGGGACGATATGGA-
GAAGATTT-39 (forward) and 59-TGGGCA-
CAGTGTGGGTGA-39 (reverse). The efficiencies of the primers
Figure 4. Tissue localization of mucin 2 and trypsin on jejunal sections. Representative immunostaining of mucin 2 (green), trypsin (red),
with nuclei counterstaining (blue) for jejunal sections corresponding to SHAM animals or animals subjected to SAO protocol with luminal inhibition
with acarbose (ACA), tranexamic acid (TA) or nafamostat mesilate or without inhibitors (SAO30).
doi:10.1371/journal.pone.0040087.g004
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mRNA expression relative to b-actin mRNA expression.
Epithelial Cell Culture
IEC-18 cells (CRL-1589; ATCC, Manassas, VA), a cell line
derived from the ileum of rat intestine, were grown in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 4 mM L-
glutamine, 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 0.1
Unit/ml bovine insulin, 95%; and fetal bovine serum, 5%.
Immunocytochemistry
IEC-18 cells were grown in 8-well culture slides (BD Biosciences,
SanJose,CA)until100%confluencywasreached.Onthedayofthe
experimentthemediawasremovedandcellswererinsedthreetimes
with PBS followed by incubation with serum free media (SFM) with
or without porcine trypsin (5 mM, Sigma-Aldrich) for 60 min. Cells
were fixed with 4% paraformaldehyde in PBS followed by blocking
and permeabilization in 2% BSA in 0.1% PBS-T for 1 hr at room
temperature. The slides were incubated overnight with primary
antibody E-cadherin 1:250 (Abcam) followed by incubation with
FITC secondary antibody (Santa Cruz Biotechnology) and Alexa
FluorH 568 phalloidin (Invitrogen). Slides were observed using an
inverted microscope (206objective) using the appropriate fluores-
cent filters.
Mucin Layer Addition to Epithelial Cells In-Vitro
IEC-18 cells were grown in 10 ml Transwell dishes (0.4-mm
filter; Corning-Costar Corp) until 100% confluency. For the
experiment the media was removed and cells were rinsed three
times with phosphate buffered saline (PBS), the basolateral side
was filled with SFM and the apical side was covered with or
without a mucin film (,400 mm, 10% in SFM, porcine stomach;
Sigma-Aldrich, St. Louis, MO). SFM with or without 5 mM
trypsin was carefully added to the apical side. Cells were incubated
for 60 min at 37uC.
Cell Lysis
After completion of the mucin layer assay, cell media was
removed and the cells were rinsed three times with PBS, scraped
and lysed for Western blot analysis in RIPA buffer (Thermo
Scientific, Rockford, IL) containing 1 mM proteinase (Sigma-
Aldrich) and phosphatase (Thermo Scientific) inhibitors cocktail.
Cells were transferred to Eppendorf tubes followed by incubation
with agitation for 10 min at 4uC and centrifugation at 4uC for
10 min at 13,000 rpm. Total protein concentration in the
supernatant was determined with the bicinchoninic acid protein
assay.
Paracellular Flux Measurement
The cells were seeded on 12-well Transwell plates (0.4-mm filter;
Corning-Costar Corp, Cambridge, MA) to 100% confluency.
FITC-dextran (20 kDa, 50 mg/ml, Sigma-Aldrich) in SFM with
or without trypsin was added to the apical side of the epithelial
cells with or without a mucin layer (see above). Cells were
incubated for 60 min at 37uC, media from the bottom chamber
was collected every 10 min and the amount of dextran in the
basolateral side was measured (SpectraMax Gemini XS) at 492/
Figure 5. Mucin isoforms are degraded and MUC2 mRNA is up-regulated during intestinal ischemia. Western blot for mucin 2 and
mucin 13 in jejunal homogenates of SHAM animals or animals subjected to SAO protocol with luminal inhibition with acarbose (ACA), tranexamic
acid (TA) or nafamostat mesilate or without (NI) (A). Density levels measurement of mucin 2 (B) and mRNA expression of MUC2 (C). Mucin 13 density
levels of different fragments (D). Values are mean6SEM (n=4)/group **P,0.001 compared to SHAM, {{{P,0.0001 compared to SAO30, {P,0.05
and {{P,0.001 compared to ACA.
doi:10.1371/journal.pone.0040087.g005
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Western Blot
20 mg of protein of cell lysate or tissue homogenate were
separated by SDS-PAGE. Membranes were incubated with
primary antibodies as follows: mucin2, mucin13 and trypsin
1:1000 (Santa Cruz Biotechnology), pancreatic amylase 1:1000
(GeneTex, San Antonio, TX), intra- and extra-cellular domains of
E-cadherin and TLR4 1:1000 (Abcam), intracellular domain of
TLR4 1:1000 (Invitrogen). Secondary antibodies were diluted
1:20000 (Santa Cruz Biotechnology) and detected with Super
Signal West Pico (Thermo Scientific). The exposed x-ray films
were scanned and label intensity was measured using digital gel
analysis (NIH ImageJ software).
Statistical Analysis
Results are presented as mean6SEM. Unpaired comparisons of
mean values between groups were carried out by one-way
ANOVA followed by Bonferroni post-hoc comparisons. P,0.05
was considered significant.
Results
Enzyme Activity in Intestinal Tissues
In order to determine the role of digestive enzymes in mucin
disruption during ischemia, we used three inhibitors: acarbose, an
a-glucosidase and pancreatic a-amylase inhibitor [25], tranexamic
acid, a trypsin and plasminogen inhibitor [22,26,27]; and
nafamostat mesilate, a broad spectrum serine protease inhibitor
[28]). Acarbose inhibited amylase non-competitively with an
inhibitory constant Ki =0.48 mM and nafamostat mesilate
inhibited trypsin competitively with Ki =0.78 mM (Figure 1A
and 1B). Tranexamic acid inhibited trypsin competitively with Ki
=56.5 mM [3].
The activity levels of amylase and trypsin in intestine
homogenates during ischemia were significantly higher compared
to levels in sham animals (SHAM) and this activity was decreased
in the groups treated with their respective inhibitors (Figures 2A,
B). The activity of luminal contents (LUM CONT) alone in the
sham group was significantly elevated as compared to the activity
of tissue homogenates of all groups (Figures 2A, B). However,
Western blot for amylase and trypsin in intestinal homogenates for
all groups showed no change in the amount of protein, implying
that the enzymes are being activated during ischemia (Figure 2C–
E). In-situ zymography of trypsin activity in the intestinal wall
(Figure 3) revealed no trypsin activity in the SHAM group and
high levels of trypsin activity for the ischemic group without
protease inhibitors (SAO30) and for the ischemic group with
acarbose treatment (SAO30+ACA). Ischemic groups treated with
tranexamic acid (SAO30+TA) and nafamostat mesilate
(SAO30+ANGD) had undetectable levels of trypsin activity in
the intestinal wall.
Figure 6. Epithelial barrier is disrupted during intestinal ischemia. Western blot for intra- and extra-cellular domains of E-cadherin in jejunal
homogenates of SHAM animals or animals subjected to SAO protocol with luminal inhibition with acarbose (ACA), tranexamic acid (TA) or nafamostat
mesilate or without (NI) (A) with corresponding density measurements. Values are mean6SEM (n=4)/group * P,0.01 compared to sham, {{
P,0.001 as compared to ACA, { P,0.01 as compared to TA (B). Representative micrographs of jejunal sections for groups described above, showing
localization of FITC-dextran (green) with nuclei counterstaining (blue) (C).
doi:10.1371/journal.pone.0040087.g006
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To determine whether digestive enzymes mediate mucin
degradation we visualized mucin 2 and trypsin with immunohis-
tochemistry techniques. In the sham group (SHAM) mucin 2 had
the appearance of an intact layer (Figure 4) while in the ischemic
group without protease inhibitors (SAO30) this layer was
discontinuous. The tips of the villi were destroyed and trypsin
penetrated into the intestinal wall. In the presence of inhibitors the
mucin 2 layer also appeared less dense as compared to the sham
group. The protein levels of mucin 2 in intestine homogenates, as
determined by Western blot (Figure 5A, B), were significantly
decreased in the ischemic group as well as in the ischemic groups
treated with tranexamic acid (SAO30+TA) and nafamostat
mesilate (SAO30+ANGD). This evidence suggests that trypsin
may not mediate mucin 2 degradation. Mucin 2 density in the
ischemic group treated with acarbose (SAO30+ACA) was also
decreased as compared to the sham group and was on average
slightly greater than in the other ischemic groups (not significant).
In order to determine whether ischemia affects MUC2 mRNA
synthesis we performed real-time quantitative PCR; the results
show that mRNA relative levels in intestinal tissues were higher
after 30 min of ischemia. mRNA levels in ischemic group without
protease inhibition (SAO30) were significantly elevated compared
to SHAM while the mRNA relative levels for the ischemic groups
with luminal inhibitor treatments (SAO30+ACA, SAO30+TA,
SAO30+ANGD) were not significantly increased compared to
sham (Figure 5C).
Mucin13 Fragmentation during SAO
Western blot analysis indicates that the digestive enzymes were
not associated with a significant shift in the density levels of the
intact molecule of mucin 13 (56 kDa) in any of the groups
(Figure 5A, B).
Low molecular weight bands were observed in addition to the
band corresponding to the whole molecule. The sham group
(SHAM) had low molecular weight bands around 24 kDa and to
lesser degree at 20 kDa. The density of these bands was
significantly decreased in the ischemic group without luminal
inhibitors (SAO30) and in the groups with trypsin inhibition by
either tranexamic acid (SAO30+TA) or nafamostat mesilate
(SAO30+ANGD) (Figure 5D). The ischemic group with amylase
inhibition by acarbose (SAO30+ACA) had higher density levels of
these bands. There was also another band around 17 kDa that was
not present in the sham group and appeared during ischemia
(Figure 5A). Density of this band was significantly greater in the
ischemic group alone and in the groups with luminal inhibition by
tranexamic acid or nafamostat mesilate compared to sham, and
was present to a lesser degree in the acarbose group (not
significant) (Figure 5D).
Intestinal Ischemia Is Accompanied by E-cadherin
Degradation and Increased Transport of FITC-dextran
Into the Intestinal Wall
In order to determine whether mucin disruption during
intestinal ischemia is accompanied by disruption of epithelial cell
integrity we determined the levels of both intra- and extra-cellular
domains of E-cadherin by Western blot (figure 6A, B). Both
domains of E-cadherin were degraded after 30 min ischemia
without protease inhibitor (SAO30). Inhibition of amylase
(SAO30+ACA) and trypsin (SAO30+TA and SAO30+ANGD)
yielded levels of E-cadherin that were higher than those in the
ischemic group alone. However, these differences were not
statistically significant.
Figure 7. TLR4 is degraded during intestinal ischemia. Western blot for intra- and extra-cellular domains of TLR4 in jejunal homogenates of
SHAM animals or animals subjected to SAO protocol with luminal inhibition with acarbose (ACA), tranexamic acid (TA) or nafamostat mesilate or
without (NI) (A) with corresponding density level measurements (B). Immunohistochemistry of intra- and extra-cellular domains of TLR4 (brown) and
nuclei counterstaining with hematoxylin (blue) (C). Values are mean6SEM (n=4)/group *P,0.05 compared to SHAM.
doi:10.1371/journal.pone.0040087.g007
Mucin Breakdown in the Ischemic Rat Intestine
PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e40087FITC-dextran transport measurements show that in the sham
group (SHAM) FITC-dextran remained intraluminal, lining the
villi with negligible transfer from the lumen of the intestine into the
intestinal wall (Figure 6C). In contrast, the ischemic groups
without luminal inhibitors (SAO30) had erosion at the villi tips
with observable FITC-dextran infiltration into the intestinal wall.
Although the ischemic groups with enzyme inhibitors
(SA030+ACA, SAO30+TA, SAO30+ANGD) had a preserved
villus structure as seen on frozen sections, there was some
penetration of FITC-dextran into the intestinal wall.
TLR4 Is Degraded during Intestinal Ischemia
In order to determine whether mucin disruption is also
accompanied by the degradation of typical membrane surface
proteins, we determined the levels of the intra- and extra-cellular
domains of TLR4 (Figure 7). Western blot analysis reveals that
both domains of TLR4 were degraded after 30 min ischemia
(SAO30) and this was not significantly reversed by inhibition of
amylase (SAO30+ACA) and trypsin (SAO30+TA,
SAO30+ANGD) (Figure 7A, B). Immunolabeling in the sham
animals (SHAM) demonstrated both domains of TLR4 visible
along the villi. In contrast, after 30 min ischemia without luminal
inhibition of digestive enzymes (SAO30), visible morphological
damage was accompanied by disruption of both domains of TLR4
(Figure 7C). Ischemic groups with luminal inhibition of amylase or
trypsin (SA30+ACA, SAO30+TA, SAO30+ANGD) had preser-
vation of the villus structure and greater staining than the ischemic
group without inhibitors.
Mucin Layer Reduces Trypsin-Mediated E-Cadherin and
TLR4 Degradation in Intestinal Epithelial Cells In Vitro
In order to determine if trypsin disrupts the epithelial cells in a
like manner to that observed in vivo in the rat model of intestinal
ischemia and whether addition of a mucin layer prevents this, we
studied an in vitro model using a monolayer of rat intestinal
epithelial cells. After incubation of IEC-18 cells for 1 hour with
Figure 8. E-cadherin localization in intestinal epithelial cells after trypsin exposure. Representative micrographs of IEC-18 cells
immunostained for the intra-cellular domain of E-cadherin (green), actin (red), and nuclei (blue) after exposure to serum free medium (SFM) with
different trypsin concentrations.
doi:10.1371/journal.pone.0040087.g008
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decreased without alteration in cell shape or the monolayer
(Figure 8). At higher trypsin concentrations, the epithelial actin
cytoskeleton started to disappear, the cells retracted and the
monolayer began to disintegrate. Western blot for both intra- and
extra-cellular domains of E-cadherin revealed degradation of this
protein in whole-cell lysates after one hour incubation with serum
free media containing 5 mM trypsin (SFM+Try) (Figure 9). This is
supported by reduced density of the whole molecule as seen with
antibodies against both intra- and extra-cellular domains as well as
the appearance of lower molecular weight bands. Application of a
layer of 10% mucin on the apical side of the cells prior to the
addition of the serum free media with trypsin resulted in higher
density of the whole molecule of both intra- and extra-cellular
domains of E-cadherin and decreased density of their correspond-
ing lower molecular weight bands (Figure 9). Similarly, density
levels for the extracellular domain of TLR4 were reduced in
intestinal epithelial cells that were treated with serum free media
containing trypsin (SFM+Try) as compared to those without
trypsin treatment (SFM) (Figure 10). A mucin layer on the apical
side of the cells reduced degradation of the TLR4 extra-cellular
domain. Density levels of the intra-cellular domain of TLR4 were
unchanged in all groups.
Mucin Layer Reduces Trypsin-Mediated FITC-dextran
Transport
In order to assess the ability of the mucin layer to act as a barrier
against trypsin-mediated epithelial cell permeability increases, we
measured the rate at which FITC-dextran (20 kDa) diffused across
the epithelial cell monolayer (Figure 11). The addition of 5 mM
trypsin in serum free media (SFM+Tryp) to the apical side of the
IEC-18 cell monolayer resulted in significantly increased FITC-
dextran levels on the basolateral side of the cell monolayer as
compared to cells without apical trypsin (SFM). When a mucin
layer was added on the apical side prior to addition of serum free
media with or without trypsin, the levels of FITC-dextran
measured on the basolateral side were not significantly different
between the groups. In addition, diffusion of FITC-dextran across
the epithelial cell monolayer in cultures not exposed to protease
but containing a mucin layer was significantly reduced as
compared to cells that did not have a mucin layer.
Figure 9. Mucin layer protects E-cadherin on intestinal epithelial cells from trypsin-mediated degradation. Western blot for intra- and
extra-cellular domains of E-cadherin of IEC-18 cells without a mucin layer after exposure with serum free without and with trypsin (SFM and SFM+Try
respectively) and IEC-18 cell with a mucin layer after exposure to serum free media with or without trypsin (SFM+Mucin and SFM+Mucin +Try) (A)
with corresponding density levels measurements (B). Values are mean6SEM (n=4)/group, **P,0.001 and ***P,0.0001 compared to SFM;
{{P,0.001, {{{P,0.0001 compared to SFM+Mucin; and {{P,0.001, {{{P,0.0001 compared to SFM+Mucin+Try.
doi:10.1371/journal.pone.0040087.g009
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The importance of mucin in the breakdown of the intestinal
mucosal function in ischemia and hemorrhagic shock was first
suggested in the 1960s [29]. Since then a number of investigators
have established a correlation between the loss of the intestinal
mucus layer and increased intestinal injury during hemorrhagic
shock [4] and sepsis [30,31]. In a recent study we showed that 30
minutes of intestinal ischemia results in mucin disruption and
transport of digestive enzymes from the lumen of the intestine into
the intestinal wall and subsequently the systemic circulation [22].
We also showed that among the serine proteases, trypsin appears
to play an important role in the injury observed during intestinal
ischemia [22].
In this study we demonstrated in vivo with ischemic bowel and
endogenous digestive enzymes in the intestinal lumen, as well as in
vitro using intestinal epithelial cell cultures and trypsin in the
culture media, that degradation or absence of mucin results in loss
of epithelial function as a barrier. In both cases we observed loss of
E-cadherin, increased permeability to FITC-dextran, and degra-
dation of TLR4. Trypsin concentration in the rat intestinal lumen
has been reported to be between 1 to 40 mM [32,33]; the typical
trypsin concentration used to pass cells in cell culture is 0.5 g/L
(22 mM) [34]. In the present studies, we show that incubation of
intestinal epithelial cells with 5 mM trypsin for one hour is
sufficient to degrade E-cadherin and TLR4 without destroying the
monolayer (Figure 8). We demonstrated in vivo that sham animals
have an intact mucin layer with preserved epithelial cell integrity
and function; similarly we showed in vitro that having a mucin
layer on the apical side of the cell monolayer protects the intestinal
epithelial cells against trypsin-mediated disruption (Figures 9
and10). Collectively these results suggest that if digestive enzymes
such as trypsin are given the opportunity to come in contact with
enterocytes at concentrations normally found in the intestinal
lumen the result will be loss of integrity and function of the
epithelial barrier.
An intact mucin layer in normal intestine is then important to
protect epithelial membrane proteins against enzymatic attack; for
instance, degradation of E-cadherin junctions results in increased
epithelial permeability. Degradation of membrane receptors, such
as TLR4, disrupts the usual pathway for TLR4 signaling after
binding of lipopolysaccharides after as little as 30 min of ischemia.
It remains to be investigated whether degradation of the
extracellular domain of TLR4 may in itself initiate a signaling
cascade, as has been reported for TLR5 and TLR15 [35,36].
In this study we also showed in vivo that mucin disruption
during early periods of intestinal ischemia is not directly mediated
by trypsin. Mucin 2 and mucin 13 are degraded during ischemia
but this disruption is not prevented by the inhibition of trypsin
with tranexamic acid or nafamostat mesilate (Figure 5). There is
Figure 10. Mucin layer protects TLR4 on intestinal epithelial cells from trypsin-mediated degradation. Western blot for intra- and extra-
cellular domains of E-cadherin of TLR4 cells without a mucin layer after exposure with serum free without and with trypsin (SFM and SFM+Try
respectively) and IEC-18 cell with a mucin layer after exposure to serum free media with or without trypsin (SFM+Mucin and SFM+Mucin +Try) (A)
with corresponding density levels measurements (B). Values are mean6SEM (n=4)/group, **P,0.001 compared to SFM, {{P,0.001 compared to
SFM+Mucin, and {P,0.05compared to SFM+Mucin+Try.
doi:10.1371/journal.pone.0040087.g010
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with acarbose, which may suggest an indirect role of pancreatic
amylase; the role of amylase remains to be further investigated.
Furthermore the ischemic groups treated with luminal injection of
enzyme inhibitors had reduced enzymatic activity and these
groups had less visible injury as compared to the ischemic group
without inhibitors. These results suggest that individual digestive
enzymes or a combination of them mediate epithelial cell
disruption but not mucin disruption.
Goblet cell-derived mucin (mucin 2) in the mucus layer has been
proposed to be the major barrier against passage of high-
molecular weight compounds across the intestinal barrier [37].
The level of the mucus layer is determined by a balance between
secretion and degradation of this protein. A variety of stimuli in
different pathologies may lead to mucin over-secretion or cessation
of secretion [38,39,40,41,42]. In the current results we show that
after 30 min ischemia the level of MUC2 mRNA is significantly
increased as compared to the sham group. This rapid response
after a relatively short period of ischemia may serve to replenish
mucin 2 in the mucus layer, which may be a critical protection
mechanism to prevent the escape of luminal digestive enzymes.
Further studies are necessary to determine whether MUC2
mRNA is translated if longer periods of ischemia and reperfusion
are present and if under these conditions the rate of mucin
degradation is greater than the rate of secretion, resulting in
irreversible injury.
While the importance of the epithelial barrier in intestinal
homeostasis is well recognized, the significance of the mucus layer
with regard to passage of digestive enzymes remains less certain.
We show here in vitro that addition of an exogenous layer of mucin
to the apical side of intestinal epithelial cells significantly reduces
trypsin-mediated disruption of E-cadherin and TLR4 but does not
completely prevent it. One explanation could be that the
exogenous mucin as used in the current experiment is of gastric
origin, which contains MUC5 instead of MUC2. Although from
different origins these two mucin isoforms have similar general
characteristics [43,44]. In addition, it may be that complete
protection against trypsin degradation by an exogenous mucin
layer on an epithelial monolayer is not achieved because the
mucin used in this experiment is partially purified and may not
form a complete barrier as it is found in vivo.
In this study we investigate how two different mucin isoforms
found in the small intestine (mucin2 and mucin13) are disrupted
after splanchnic ischemia. However we cannot rule out the
possible role of other mucin isoforms that although present in
soluble form do not comprise a major part of the mucosal barrier;
for instance mucin4, which is localized in the paneth cells but not
in goblet cells of the small intestine [45] or mucin1 or mucin3
different types of membrane bound mucin. Functional studies to
determine the role of mucin2 or mucin13 during intestinal
ischemic injury present some challenges. Up to date only a
knockout mice model for mucin2 gene (MUC2) is available. This
model was first described in 2002 [46] and since then the effect of
mucin2 deficiency has been largely characterized for the large
intestine but less is known in this regard about the small intestine.
The MUC2
2/2 mice have significantly lower weight at 5 weeks
after weaning (12 g as compared to 20 g for their wild type litter
mates) [47]. MUC2
2/2 mice also develop colitis as early as
5 weeks manifest in form of diarrhea, gross bleeding and lethargic
state [46,47]. MUC2
2/2 mice have goblet cells with abnormal
morphology, decreased epithelial barrier function, and altered
expression in tight junction-related genes such as upregulation of
claudin-10 and downregulation of claudin1 and claudin 5 [46,48].
In addition there is upregulation of genes stimulating cell growth
which manifests in intestinal tumor formation with spontaneous
progression to invasive carcinoma later in life [46]. Due to the fact
that MUC2
2/2 mice do not have normal intestinal function after
weaning which is usually the time used in experimental studies,
MUC2
2/2 mice are not appropriate to study the breakdown of
the mucosal epithelial barrier because the barrier is already altered
in this model.
In conclusion, the results presented here confirm that mucin in
the mucus layer is a barrier that protects the intestinal epithelium
against enzymatic auto-digestion. During ischemia mucin isoforms
are degraded, which may stimulate synthesis of new mucin to
restore the damaged barrier. As mucin is degraded and the barrier
function of the mucus layer is thus compromised, digestive
enzymes in the lumen of the intestine are allowed to come into
contact with the epithelium with consequent loss of epithelial cell
integrity and function. This cascade of events results in intestinal
injury, transport of digestive enzymes into the systemic circulation
and subsequent shock.
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Figure 11. Mucin layer reduces FITC-dextran diffusion across
the intestinal epithelial cells monolayer. Rate of diffusion of FITC-
dextran across mucin alone, IEC-18 cell monolayer alone, or IEC-18 cell
monolayer with a mucin layer after exposure to serum free media alone
(SFM) or serum free media with trypsin (SFM+Try). Values are mean 6
SEM (n=4), **P,0.001 compared to SFM cells alone, {{{P,0.001
compared to SFM+tryp cells alone, 111P,0.0001 compared the other
groups. (One-way Anova fallowed by Bonferroni’s post-hoc).
doi:10.1371/journal.pone.0040087.g011
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